TN2014000218A1 - Kinase inhibitors - Google Patents

Kinase inhibitors

Info

Publication number
TN2014000218A1
TN2014000218A1 TNP2014000218A TN2014000218A TN2014000218A1 TN 2014000218 A1 TN2014000218 A1 TN 2014000218A1 TN P2014000218 A TNP2014000218 A TN P2014000218A TN 2014000218 A TN2014000218 A TN 2014000218A TN 2014000218 A1 TN2014000218 A1 TN 2014000218A1
Authority
TN
Tunisia
Prior art keywords
kinase inhibitors
formula
diseases
compounds
useful
Prior art date
Application number
TNP2014000218A
Inventor
Niel Monique Bodil Van
Nicholas Charles Ray
Lilian Alcaraz
Terry Aaron Panchal
Andrew Stephen Robert Jennings
Elisabetta Armani
Andrew Peter Cridland
Cristopher Hurley
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/074446 external-priority patent/WO2013083604A1/en
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of TN2014000218A1 publication Critical patent/TN2014000218A1/en

Links

Abstract

Compounds of formula (I) or a pharmaceutically acceptable salt thereof: formula (I) wherein R2, W, A, Y and R1 are as defined in the specification, are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
TNP2014000218A 2012-10-10 2014-05-16 Kinase inhibitors TN2014000218A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12187931 2012-10-10
PCT/EP2012/074446 WO2013083604A1 (en) 2011-12-09 2012-12-05 Kinase inhibitors

Publications (1)

Publication Number Publication Date
TN2014000218A1 true TN2014000218A1 (en) 2015-09-30

Family

ID=47010378

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2014000218A TN2014000218A1 (en) 2012-10-10 2014-05-16 Kinase inhibitors

Country Status (1)

Country Link
TN (1) TN2014000218A1 (en)

Similar Documents

Publication Publication Date Title
PH12014501277A1 (en) Kinase inhibitors
PH12014501278A1 (en) Kinase inhibitors
PH12019501321B1 (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
SA515360469B1 (en) Heterocyclic compounds for inhibiting glutaminase and their methods of use
PH12015502628A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
MX2017013797A (en) Janus kinase inhibitor.
PH12016500024A1 (en) Bromodomain inhibitor
MD20170016A2 (en) Aminopyrimidinyl compounds as JAK inhibitors
MX345928B (en) Therapeutically active compositions and their methods of use.
MX2015016344A (en) Imidazopyrrolidinone derivatives and their use in the treatment of disease.
UA111382C2 (en) Protein kinase inhibitors
TN2014000138A1 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
AU2012214029A8 (en) Rorgammat inhibitors
BR112015029970A2 (en) kinase inhibitors
MX2015016421A (en) Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease.
JO3115B1 (en) Pyridazinone Compounds and Their Use as DAAO Inhibitors
MX2015016425A (en) Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease.
GB201209587D0 (en) Therapeutic compounds
MX2015013414A (en) N-(2-cyano heterocyclyl)pyrazolo pyridones as janus kinase inhibitors.
MX342153B (en) Compounds for the treatment and prophylaxis of respiratory syncytial virus disease.
PH12015500399A1 (en) Azaindolines
MX2015012386A (en) Cdk9 kinase inhibitors.
MX2015012153A (en) Pyrrolopyrimindine cdk9 kinase inhibitors.
GEP201706614B (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
TN2014000218A1 (en) Kinase inhibitors